RCKT icon

Rocket Pharmaceuticals

195 hedge funds and large institutions have $233M invested in Rocket Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 81 increasing their positions, 47 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

48% less first-time investments, than exits

New positions opened: 41 | Existing positions closed: 79

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

68% less capital invested

Capital invested by funds: $722M → $233M (-$489M)

Holders
195
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.71M
Puts
$1.22M
Net Calls
Net Calls Change

Top Buyers

1 +$16M
2 +$11.6M
3 +$10.1M
4
Two Sigma Investments
Two Sigma Investments
New York
+$8.74M
5
Millennium Management
Millennium Management
New York
+$8.11M

Top Sellers

1 -$84.2M
2 -$32.2M
3 -$16.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$9.85M
5
State Street
State Street
Massachusetts
-$8.93M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$295K
77
$281K
78
$275K
79
$272K
80
$255K
81
$247K
82
$245K
83
$245K
84
$238K
85
$226K
86
$226K
87
$208K
88
$187K
89
$184K
90
$181K
91
$175K
92
$172K
93
$160K
94
$156K
95
$156K
96
$156K
97
$142K
98
$139K
99
$137K
100
$134K